These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 26361329)
1. Perfusion Intensity Correlates with Expression Levels of Psoriasis-Related Genes and Proteins. Hendriks AG; Steenbergen W; Zeeuwen PL; Schalkwijk J; Hondebrink E; Klitsie MA; Schreurs R; van de Kerkhof PC; Seyger MM Skin Pharmacol Physiol; 2015; 28(6):296-306. PubMed ID: 26361329 [TBL] [Abstract][Full Text] [Related]
2. Clearing of psoriasis documented by laser Doppler perfusion imaging contrasts remaining elevation of dermal expression levels of CD31. Hendriks AG; van de Kerkhof PC; de Jonge CS; Lucas M; Steenbergen W; Seyger MM Skin Res Technol; 2015 Aug; 21(3):340-5. PubMed ID: 25534374 [TBL] [Abstract][Full Text] [Related]
3. Dual wavelength (532 and 633 nm) laser Doppler imaging of plaque psoriasis. Murray AK; Herrick AL; Moore TL; King TA; Griffiths CE Br J Dermatol; 2005 Jun; 152(6):1182-6. PubMed ID: 15948979 [TBL] [Abstract][Full Text] [Related]
4. Whole field laser Doppler imaging of the microcirculation in psoriasis and clinically unaffected skin. Hendriks AG; Steenbergen W; Hondebrink E; van Hespen JC; van de Kerkhof PC; Seyger MM J Dermatolog Treat; 2014 Feb; 25(1):18-21. PubMed ID: 23441953 [TBL] [Abstract][Full Text] [Related]
5. Histological and transcriptional study of angiogenesis and lymphangiogenesis in uninvolved skin, acute pinpoint lesions and established psoriasis plaques: an approach of vascular development chronology in psoriasis. Henno A; Blacher S; Lambert CA; Deroanne C; Noël A; Lapière C; de la Brassinne M; Nusgens BV; Colige A J Dermatol Sci; 2010 Mar; 57(3):162-9. PubMed ID: 20071151 [TBL] [Abstract][Full Text] [Related]
6. Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis. Henno A; Blacher S; Lambert C; Colige A; Seidel L; Noël A; Lapière C; de la Brassinne M; Nusgens BV Br J Dermatol; 2009 Mar; 160(3):581-90. PubMed ID: 18945297 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris. Chiricozzi A; Suárez-Fariñas M; Fuentes-Duculan J; Cueto I; Li K; Tian S; Brodmerkel C; Krueger JG Br J Dermatol; 2016 Jan; 174(1):136-45. PubMed ID: 26189551 [TBL] [Abstract][Full Text] [Related]
8. Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin. Keijsers RR; van der Velden HM; van Erp PE; de Boer-van Huizen RT; Joosten I; Koenen HJ; van de Kerkhof PC Br J Dermatol; 2013 Jun; 168(6):1294-302. PubMed ID: 23330679 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708 [TBL] [Abstract][Full Text] [Related]
10. Early inflammatory changes in the "perilesional skin" of psoriatic plaques: is there interaction between dendritic cells and keratinocytes? Komine M; Karakawa M; Takekoshi T; Sakurai N; Minatani Y; Mitsui H; Tada Y; Saeki H; Asahina A; Tamaki K J Invest Dermatol; 2007 Aug; 127(8):1915-22. PubMed ID: 17446902 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-1: a key inflammatory mediator in psoriasis? Mee JB; Cork MJ; di Giovine FS; Duff GW; Groves RW Cytokine; 2006 Jan; 33(2):72-8. PubMed ID: 16460958 [TBL] [Abstract][Full Text] [Related]
13. In vivo quantification of microvessels in clinically uninvolved psoriatic skin and in normal skin. Hern S; Mortimer PS Br J Dermatol; 2007 Jun; 156(6):1224-9. PubMed ID: 17459047 [TBL] [Abstract][Full Text] [Related]
14. Expression of Th1 and Th2 cytokine-associated transcription factors, T-bet and GATA-3, in peripheral blood mononuclear cells and skin lesions of patients with psoriasis vulgaris. Zhu K; Ye J; Wu M; Cheng H Arch Dermatol Res; 2010 Sep; 302(7):517-23. PubMed ID: 20333526 [TBL] [Abstract][Full Text] [Related]
15. Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers. van Lingen RG; Poll MK; Seyger MM; de Jong EM; van de Kerkhof PC; van Erp PE Arch Dermatol Res; 2008 Nov; 300(10):561-7. PubMed ID: 18496701 [TBL] [Abstract][Full Text] [Related]
16. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. Mashiko S; Bouguermouh S; Rubio M; Baba N; Bissonnette R; Sarfati M J Allergy Clin Immunol; 2015 Aug; 136(2):351-9.e1. PubMed ID: 25792465 [TBL] [Abstract][Full Text] [Related]
17. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. Schulz BS; Michel G; Wagner S; Süss R; Beetz A; Peter RU; Kemény L; Ruzicka T J Immunol; 1993 Oct; 151(8):4399-406. PubMed ID: 7691948 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of mRNA expression of survivin and human beta-defensin-3 in lesions of psoriasis vulgaris. Wang F; Zhang X; Xia P; Zhang L; Zhang Z Eur J Dermatol; 2016; 26(1):28-33. PubMed ID: 26771657 [TBL] [Abstract][Full Text] [Related]
19. The role of interleukin-12 in the pathogenesis of psoriasis. Shaker OG; Moustafa W; Essmat S; Abdel-Halim M; El-Komy M Clin Biochem; 2006 Feb; 39(2):119-25. PubMed ID: 16386240 [TBL] [Abstract][Full Text] [Related]
20. Ustekinumab improves psoriasis-related gene expression in noninvolved psoriatic skin without inhibition of the antimicrobial response. Baerveldt EM; Onderdijk AJ; Kurek D; Kant M; Florencia EF; Ijpma AS; van der Spek PJ; Bastiaans J; Jansen PA; van Kilsdonk JW; Laman JD; Prens EP Br J Dermatol; 2013 May; 168(5):990-8. PubMed ID: 23278632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]